Single award · contract
Moderna Therapeutics, Inc:advance the Development of an Mrna Vaccine for the Prevention of Zika Virus:
Award ID: HHSO100201600029C
A single federal award, with both ends of the trail linked.
$73M
Total award value
Award HHSO100201600029C is a contract from the Department of Health and Human Services to Modernatx, Inc., $73M obligated, FY2016 to FY2024, for Moderna Therapeutics, Inc:advance the Development of an Mrna Vaccine for the Prevention of Zika…. The work is performed in Massachusetts. It is classified as PSC AN13 (Health R&D Services; Health Care Services; Experimental Development) and NAICS 541711 (Research and Development in Biotechnology). Source
Description
Moderna Therapeutics, Inc:advance the Development of an Mrna Vaccine for the Prevention of Zika Virus:: Igf::ot::igf
Award details
Award typeContract
PIIDHHSO100201600029C
Action date2016
Period94 mo
Awarding agencyDepartment of Health and Human Services →
RecipientModernatx, Inc. →
Place of performanceMassachusetts →
CategoryPSC AN13NAICS 541711
Competed?Not recordedSource
Total (exact)$72,965,186
More awards to Modernatx, Inc.
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.